Vectors for gene transfer and gene therapy were developed which combine the advantages of the integrase and recombinase systems. This was achieved by inserting two loxP sites for specific DNA excision into an MESV based retroviral vector. We show that this 'retroviral lox system' allows the infection of cells and the expression of transferred genes. In addition, we constructed an efficient retrovirus-based expression system for a modified Cre recombinase. Functional tests for DNA excision from Integrated retroviral lox vectors were performed by the use of a negative selectable marker gene (thymldine kinase). Cre expression in cells infected with retroviral lox vectors and subsequent BrdU selection for cells in which site-specific recombination has occurred results in large numbers of independent cell clones. These results were confirmed by detailed molecular analysis. In addition we developed retroviral suicide vectors in which the enhancer/promoter elements of both LTRs were replaced by lox sequences. We show that /ox-sequences located in the LTRs of retroviral vectors are stable during retroviral replication. Potential applications of this system would be the establishment of revertants of retrovirus-infected cells by controlled excision of nearly the complete proviral DNA.
INTRODUCTION
Retroviral vectors are commonly used for gene transfer and gene therapy (1) (2) (3) . They are derivatives of retroviruses which integrate DNA into host genomes as an obligatory step during their life cycle (4) . Retroviral vectors infect a wide range of mitotically active cells by binding to specific receptors. The viral RNA is reverse transcribed after infection and the proviral DNA multiplicity of infection, one or multiple copies of the retro' vector are integrated into the host genome (9) (10) (11) . In compar to other DNA transfer methods, the specific enzymatic reac decreases the risk of cell transformation (12) and leads to st integration (13) . Due to these advantages, retroviral vectors the most widely used tool for gene transfer and gene therapc applications.
Systems for site-specific recombination have been used genomic engineering of yeast (14) (15) , plant (16) (17) (18) (19) (20) (21) (22) and an cells (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) . These systems include Cre-Zox from bacteriopl PI, FLP-FRT from Saccharomyces cerevisiae and R-RS i Xygosaccharomyces rouxii (reviewed in 36). The 38 kDa recombinase from bacteriophage PI catalyzes site-specific combination between 34 bp repeats termed loxP (37, 38) . T lox sites contain two 13 bp inverted repeats separated by an asymmetrical core region. Upon binding to the inverted rer> Cre synapses with a second lox site and cleaves the DNA ir spacer region to initiate strand exchange with the synapsed partner. Site-specific recombination results in excision or invei of intervening DNA. This reaction depends on the orientatio the two lox sites (head to tail or head to head). No additional fa< are required in the recombination reaction (39, 40) .
In this article, we describe a system for the specific excisic DNA fragments from integrated retroviral vectors. This sy< allows the complete silencing of retrovirally transferred gene the excision of their ORFs. We replaced the enhancer/proir elements of retroviral LTRs by lox sites and showed that thes< sites are stable during retroviral replication. We show negative selectable marker genes allow the exclusive selectic cells in which excision has occurred. Potential applications o system described here are discussed.
MATERIALS AND METHODS

Recombinant DNA
The plasmids pJBlox7 and pJBCre31 were constructed u pJBlox7: G418 resistant, BrdU sensitive HSV-TK expression cassette from plasmid pIC19R/MCl-TK (42) was inserted as a blunted Xhol-HindUl fragment between the two lox sites (ZtomHI/blunt) of pDB5. This expression cassette contains the herpes simplex virus thymidine kinase gene driven by the promoter and a duplicated enhancer of a polyoma virus. The lox-tk-lox fragment from pDB6 was isolated as a Pvull fragment and inserted into the blunted BamHl-EcoRi sites of the retroviral vector p50-Mneo (C. Stocking). This newly created retroviral vector pJBlox7 contains the ORF for the thymidine kinase gene in an opposite orientation. Deletions in lox sites occurred frequently during construction of these plasmids. This necessitated the performance of transformations in an E.coli SURE strain (Stratagene) and the incubation of cells at 28 °C.
To create pJBCre31, the sequence for a modified ORF of the Cre recombinase was amplified by PCR using pMM23 (D. Ow) as template. Primers used for PCR were: DB14 5'-ATAITGGTACCTACCTACCArGGTGCCCAAGAA-GAAGAGGAAGGTGTCCAATTTACTGACCG-3' and DB2myc 5'-CATGCTCTAGATCAGTTCAAGTCTTCTTCA-GAAATAAGCTTTTGTTCGTTATCGCCATCTTCCAGCAG-GC-3'. PCR amplification yielded a modified ORF for the Cre recombinase with an N-terminal added Kozak sequence (43) and a nucleus localization sequence (44) . A 9E10 epitope for immunological detection (45) was added at the C-terminus. The amplified DNA was cloned as a Kpnl-Xbal fragment into pSP72 to create pSIl#13. A Kpnl-Xhol fragment of pSIl#13 was inserted into pHB40p to create pSI 1#13D. This plasmid was used for high-level expression in the T7-system. An EcoRl-Hindlll fragment of pSIl#13 was inserted into pUC-M5neo (46) replacing the neo R gene. The resulting vector pJBCre31 was used for expression in animal cell lines.
To generate the self-inactivating retroviral vector pJB VE6, the promoter/enhancer elements of the retroviral 3TJTR were replaced by a lox site. The promoter/enhancer elements in the U3 region of the 31TR of plasmid p5N-M (C. Stocking) were replaced by a BamUl-Sstl lox fragment from plasmid pED32a (D. Ow). The hyg/tk expression cassette from plasmid tgCMV/ hygtk was then inserted as a Notl fragment The opposite orientation of the ORF for the hyg/tk fusion protein was determined by restriction analysis. The resulting vector, pJBVE6, contains a wild-type (wt) 5T-TR and a 3TJTR with a lox site instead of promoter/enhancer elements. The promoter/enhancer elements in the wt 5T-TR were replaced during retroviral replication by the modified U3 region of the 3TJTR. This leads to an inactivated provirus without promoter/enhancer elements in both LTR's.
Culture, electroporation and retroviral infection of animal cells
GP-envAml2 helper cells (47) and RAT-2 fibroblasts (48), were maintained in DMEM containing 10% FCS supplemented with glutamine (2 mM). Electroporation was performed as described (49) . GP-envAml2 cells and RAT-2 cells (2 x 10 6 ) were electroporated with 10 (ig DNA (250 V and 1050 |iF). Neo 11 cells were selected with 400 \ig/ml G418 for > 2 weeks. BrdU R cells were selected with 100 (ig/ml BrdU for >2 weeks. Retroviral infection (50) was performed with different dilutions of supernatants from helper cell lines in the presence of 8 |J.g/ml polybrene. DNA isolation was performed by incubating 10 7 cells over night in 5 ml lysis buffer (containing 0.5% SDS, 300 (ig/ml proteinase K in TE-buffer) and subsequent isopropanol precipitation.
Molecular analysis
In vitro DNA amplification was performed using a Biometra Temperature Cycler with a heated cover (Biometra). Taq polymerase was added after 10 min of denaturation followed by 40 cycles of denaturation(94°C, 1 min), annealing (62°C, 1 min) and extension (72°C, 2 min). The reaction (0.5 |ig genomic template) was performed using standard conditions recommended by the polymerase supplier (Boehringer). Primers used for PCR analysis were: DB3, 5'-GAGTCAAAACTAGAGCC-3'; DB10, 5'-GATCCTCCAGCGCGGGG-3'; DB20, GCCATTTTGCAAGGCATGG and DB21, CTAGTTGTGGTTTGTCC.
PCR fragments were cloned into the Xcm\ sites of vector pXcmKnl2 (51) . Southern analysis was performed by blotting fractionated DNA onto nylon membranes (Biodyne B). Filters were hybridized and washed using conditions recommended by the membrane supplier. Radioactive labelling of DNA fragments was performed by primer extension as described previously (52) . Nucleotide sequences were determined by the dideoxynucleotide chain termination method of Sanger et at. (53) . Alkali-denatured plasmid DNA was sequenced using T7 DNA polymerase (T7 sequencing Kit, Pharmacia).
RESULTS
Functional test of pJBlox7 and pJBCre31
A retrovirus based Cre-lox excision system was designed that was made up of two components (Fig. 1) . A DNA excision cassette, including a gene for expression flanked by two loxP sites, was inserted into an MESV based retroviral vector (pJBloxT). The second component (pJBCre31) was a retrovirus based expression vector for a modified Cre recombinase (see Materials and Methods). The function of the Cre-/<xc excision system was checked in prokaryotic cells and in vitro. This was necessary as we often obtained mutated lox sites during cloning. The modifications of the ORF for the Cre recombinase made it also necessary to examine the function of the enzyme.
The Cre expression strain BNN132 (Clontech) was transformed with plasmid pJBlox7. The plasmid DNA was isolated and checked by restriction analysis for recombination (54) . We could demonstrate with DNA restriction analysis that in eight of 10 clones a complete excision of the tk-gene has occurred. In two of the 10 clones the excision was nearly complete (data not shown). Sequence analysis showed no base exchanges in the lox sites after recombination. This indicated that the pJBlox7 vector contained a functional lox system for DNA excision.
The modified Cre recombinase (pJBCre31) was functionally tested after expression by the T7-system. Plasmid pSI 1 #13D (see Materials and Methods) was transformed into the BL21DE3 strain (Cre~) and the modified Cre recombinase was expressed (55, 56) . High-level expression was checked by PAGE and immunological detection (45) using the monoclonal 9E10-antibody (Dianova). Expressed recombinase was prepared by electroelution and functionally tested in vitro with pOCUS-1 plasmids using conditions recommended by the supplier (AGS-company). This yielded 2 x 10 6 transformants per ^g DNA, showing that the modified Cre recombinase works with high efficiency.
Selection for clones after site-specific recombination
A vector with a positive and a negative selectable marker (pJBlox7) was used to show the excision of specific DNA fragments from retroviral vectors. The strategy to detect the specific DNA excision is shown in Figure 1 . The neomycin resistance gene enables selection for integration of the retroviral DNA into animal cell lines. Negative selection against thymidine kinase allows the establishment of cell clones in which site-specific recombination has occurred.
RAT-2 target cells (which do not express endogenous Tk) were infected with retroviral vectors produced by GP-envAm 12 helper cells. Neomycin resistant clones were isolated by G418 selection. The function of the thymidine kinase gene was proven by BrdU sensitivity. These results indicate that the retroviral lox vector allows infection of cells and expression of the transferred genes. The resulting cell lines RAT pJB7#2 and RAT pJB7#7 were electroporated with pJBCre31 or the control plasmid pUCM5neo, and cultivated in serial dilutions. The BrdU selection was started three days after electroporation. This period of time was chosen to ensure removal of thymidine kinase polypeptides from cells in which site-specific excision had occurred. The best time point to start BrdU selection was also determined (see below). Colonies were stained with methylene blue and counted after 2 weeks of BrdU selection. A typical result of this approach is shown in Figure 2 . We were able to isolate a sufficient number of BrdU resistant clones using this approach. The electroporation with pJBCre31 resulted in 20-fold more BrdU resistant clones than transformation with the control plasmid pUC-M5neo. This ratio is sufficient to use this method to excise specific DNA fragments from retroviral vectors. The BrdU resistant clones obtained in the control could be explained by silencing of the retroviral vector or mutations in the thymidine kinase gene.
The efficiency of the retrovirus based Cre expression plasmid pJBCre31 was compared to a standard SV40 expression vector using the same conditions for electroporation and selection of BrdU resistant clones. In these tests we obtained significantly increased (10-fold higher) recombination efficiency by using vector pJBCre31. This shows that the plasmid pJBCre31 works with high efficiency as a Cre recombinase supplier in animal cells.
Efficiency of recombination in the pJBlox7/pJBCre31-system
The frequency of specific DNA excision by Cre as a function of the time before BrdU selection was tested. To do this we determined the number of BrdU resistant clones obtained after BrdU addition on different days after transformation with the Cre expression plasmid. As shown in Figure 3 , the number of BrdU resistant clones increased with time between transformation and start of selection. We obtained a maximum of >20% BrdU resistant clones, relative to the total amount of unselected clones when BrdU selection was started 4 days after electroporation. This showed that in one out of five clonogenic cells, site-specific recombination had occurred. The efficiency of electroporation in RAT-2 fibroblasts was tested in an X-gal assay (data not shown) using 10 ng of pCMVp (Clontech). In this assay we obtained 5-10% blue-stained cells which indicates a total electroporation efficiency for RAT-2 cells of-20% (49) . The correlation between efficiency of electroporation and efficiency of recombination suggests that in the majority of the cells containing the Cre-plasmid recombination has occurred.
Molecular analysis for specific excision of DNA from retroviral lox vectors
Thirteen independent cell lines were isolated by BrdU selection as described and tested for excision at the DNA level. Nine cell lines (RAT pJB7#7 Crel-Cre9) were derived from an electroporation with the Cre expression plasmid pJB Cre31. Four cell lines (RAT pJB7#7 Col-Co4) were derived from an electroporation with the control plasmid pUC-M5neo. PCR analysis was performed to detect the recombination event in DNAs isolated from cell lines RAT pJB7#7 Crel-Cre9. The use of the primers DB3 and DB10, which bind 5' and 3' of the /ax-thymidine kinase-/at fragment lead to amplification of 0.5 kb fragments if site-specific recombination has occurred (Fig. 4A) . The specificity of the amplified signal was determined by Southern analysis. As shown in Figure 4A the expected signal was obtained in all nine cell lines. This indicates that BrdU resistance is caused by specific Cre-mediated DNA excision. These 0.5 kb fragments were also isolated, cloned and sequenced and found to contain the expected sequence with an intact lox site. No signals for the recombination event were obtained in DNAs derived from cell lines RAT pJB7#7 Col-Co4 (Fig. 4A) . The presence of the tk-gene in DNAs derived from cell lines RAT pJB7#7 Col-Co4 was determined by PCR analysis of the C-terminal part of the tk-gene (data not shown). Additional genomic Southern blot analysis was performed to test three cell lines electrotransformed with the Cre expression plasmid for complete DNA excision (Fig.  5) . In all three BrdU resistant clones only the recombinant DNA's without signals at the size corresponding to non-recombined DNA were found. These data show that the analyzed cell lines underwent complete and precise recombination.
Generation of retroviral suicide vectors containing lox sites in both LTR's
The retroviral vector pJBVE6 contains a wt 5'LTR, a hyg/tk expression cassette and a 3T.TR in which a lox site replaces the promoter/enhancer elements. This vector was used for electroporation of GP-envAM12 helper cells. The expression of the retroviral vector in the helper cell line was controlled by the 5' wt LTR. Hyg R cells were selected with 200 ng/ml hygromycin for at least two weeks. We used supematants from two independent cell lines (GPE-JBVE6#2 and GPE-JBVE6#4) for infection of RAT-2 target cells. Selection for infected cells was performed with 800 (ig/ml hygromycin. During infection of the target cells the retroviral replication leads to the replacement of the wt 5'LTR sequences by the modified 3TJTR sequences. This results in a provims without promoter/enhancer elements in both LTR's, so called 'self inactivating vector' (57) . As shown in Figure 6 infected cell lines (RAT-JB VE6#2 and RAT-JB VE6#4) were used for molecular analysis. PCR analysis was performed to answer the question, whether the U3 region of the 5T-TR is completely replaced by the modified U3 region of the 3'LTR. For this analysis one primer inside the LTR (DB20) and one primer outside the LTR (DB21) was used. The replacement of the wt U3 region by the modified U3 region leads to a shortened LTR sequence. By using the primer pair DB20 and DB21 a wt LTR template DNA leads to amplification of 1.4 kb fragments and the modified LTR template DNA leads to amplification of 1.1 kb fragments. In both infected cell lines we detected the expected signals for a modified 5T_TR sequence. The amplified DNA fragments were isolated from cell line RAT-JBVE6#4 and inserted into the Xcm\ site of vector pXcmKnl2. Sequence analysis showed the expected sequences for the modified LTR with an intact lox site. These results show that the promoter/enhancer elements of a retroviral vector can be replaced by lox sites. After excision of the self inactivating lox vector by Cre expression, only a few LTR sequences should remain in the host genome.
DISCUSSION
A DNA excision cassette including a gene for expression flanked by two loxP sites was inserted into an MESV-based retroviral vector. We have shown that this retroviral lox vector allows infection of cells and expression of the transferred genes. This system can thus be used for retroviral vector-mediated gene transfer. It should only be limited by the maximum of 8 kb DNA accepted by retroviral vectors (58) . We have also shown that Cre-mediated excision allows selection of cell clones in which excision has completely occurred. This complete excision will be important in cell lines used for quantitative assays or gene therapy (see below). The Cre expression plasmid pJBCre31 works highly efficiently. We have calculated that in most if not all cells electroporated with pJBCre31 excision must have occurred. This allows selection for the site-specific recombination event by controlled Cre expression.
A general application of retroviral lox vectors is the use in temporary and regulated gene expression. This combines the advantages of the integrase and recombinase systems: a safe and stable integration of foreign DNA with the possibility to completely down regulate the gene of interest The retroviral lox vector pJBlox7 could be used for genes with an easily detectable expression (e.g. receptors). This system could also be used in gene therapy for complete excision of the marker genes in proviral DNA (LTR; gene for therapy; lox-hyg/tk-lox, LTR.). By using both negative and positive selectable marker genes (59), the integration of the retroviral vector as well as the excision of the marker gene can be detected. This leads to the selection of cells only expressing the gene of interest without additional foreign gene products which could elicit an immune response. For a selectable excision of retrovirally transferred genes the system can be modified by flanking the gene of interest and the selectable marker gene by loxP sites. These vectors could be used in hit-and-run experiments (60/61) to prove if the expression of a regulatory protein is necessary for the maintenance of a process initiated by that protein.
We have shown that lox sites located in the LTRs of retroviral vectors are stable during retroviral replication. By using the self inactivating vector pJBVE6, the enhancer/promoter elements of both LTRs were replaced by lox sequences. Due to the loss of LTR enhancer sequences the risk for insertional mutagenesis is minimized. We predict that after site specific recombination only a single lox site flanked by a few LTR sequences remains in the host genome. This lox site is safely and stably integrated via retroviral transfer and can be used for additional recombination events. In addition this method should allow the generation of revertants of retrovirus-infected cells by controlled excision of nearly the complete proviral DNA. Further applications in gene therapy and studies for gene regulation are thus numerous.
